Skip to Content
Merck
  • c-Abl Tyrosine Kinase Adopts Multiple Active Conformational States in Solution.

c-Abl Tyrosine Kinase Adopts Multiple Active Conformational States in Solution.

Biochemistry (2016-05-12)
John Badger, Prerna Grover, Haibin Shi, Shoghag B Panjarian, John R Engen, Thomas E Smithgall, Lee Makowski
ABSTRACT

Protein tyrosine kinases of the Abl family have diverse roles in normal cellular regulation and drive several forms of leukemia as oncogenic fusion proteins. In the crystal structure of the inactive c-Abl kinase core, the SH2 and SH3 domains dock onto the back of the kinase domain, resulting in a compact, assembled state. This inactive conformation is stabilized by the interaction of the myristoylated N-cap with a pocket in the C-lobe of the kinase domain. Mutations that perturb these intramolecular interactions result in kinase activation. Here, we present X-ray scattering solution structures of multidomain c-Abl kinase core proteins modeling diverse active states. Surprisingly, the relative positions of the regulatory N-cap, SH3, and SH2 domains in an active myristic acid binding pocket mutant (A356N) were virtually identical to those of the assembled wild-type kinase core, indicating that Abl kinase activation does not require dramatic reorganization of the downregulated core structure. In contrast, the positions of the SH2 and SH3 domains in a clinically relevant imatinib-resistant gatekeeper mutant (T315I) appear to be reconfigured relative to their positions in the wild-type protein. Our results demonstrate that c-Abl kinase activation can occur either with (T315I) or without (A356N) global allosteric changes in the core, revealing the potential for previously unrecognized signaling diversity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
PD166326, ≥98% (HPLC)